Compounds > lotilibcin
Page last updated: 2024-08-03 05:04:59

lotilibcin

Description

lotilibcin: isolated from Staphylococcus aureus; structure in first source [MeSH]

Cross-References

ID SourceID
PubMed CID16184172
CHEMBL ID4788902
MeSH IDM0578263

Synonyms (12)

Synonym
wap-8294a2
lotilibcin [inn]
169148-84-9
lotilibcin
xt4808181k ,
unii-xt4808181k
wap 8294a2
lotilibcin [who-dd]
DTXSID50583257
pubchem_16184172
CHEMBL4788902
Q27293985

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1724005Antibacterial activity against Staphylococcus aureus ATCC 29213 by CLSI M07-A8 protocol based microdilution method2020Bioorganic & medicinal chemistry, 09-15, Volume: 28, Issue:18
ISSN: 1464-3391		Total synthesis and a systematic structure-activity relationship study of WAP-8294A2.
AID1724006Antibacterial activity against methicillin-resistant Staphylococcus aureus SA86 by CLSI M07-A8 protocol based microdilution method2020Bioorganic & medicinal chemistry, 09-15, Volume: 28, Issue:18
ISSN: 1464-3391		Total synthesis and a systematic structure-activity relationship study of WAP-8294A2.

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's1 (8.33)29.6817
2010's8 (66.67)24.3611
2020's2 (16.67)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
menaquinone 6
2
201820233.5high000011
lysocin e
1
202320231.0high000001
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Infections, Staphylococcal0
2
1998201119.5high001010
Leukemia L 12100
1
1998199826.0medium001000
Staphylococcal Infections0
2
1998201119.5high001010